A treatment for acute migraines has been approved for NHS use for the first time, with experts saying the move could be a “step-change” for thousands of people who suffer from the condition. The National Institute for Health and Care Excellence (Nice)
The U.S. Food and Drug Administration (FDA) has authorized a single booster dose of the Pfizer-BioNTech COVID-19 vaccine bivalent for children six months old through four years of age. At least two months prior to getting this booster, children must have completed
People suffering from migraines will soon have access to pain relief in the form of a nasal spray. The U.S. Food and Drug Administration (FDA) has approved the first calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray intended to treat migraines in
The New York Times brought the lawsuit to the EU following the failure to release President Ursula von der Leyen’s texts with Pfizer CEO Albert Bourla. This comes after Alexander Fanta, a journalist for netzpolitik.org, requested access to the texts but was refused. The case will come to
Brussels is discussing with Pfizer and BioNTech the possibility of reducing the up to 500 million COVID-19 vaccine doses the EU has committed to buy this year in return for a higher price, a source with knowledge of the talks said. Also
The European Union’s drug regulator has not identified any safety signals in the region related to U.S. drugmaker Pfizer Inc and German partner BioNTech’s updated COVID-19 shot, the agency said on Wednesday. On Friday, the U.S. Food and Drug Administration and the